Pharmaceutical industry becomes geopolitical battleground as US threatens tariffs
The global pharmaceutical industry has found itself at the heart of geopolitical and trade tensions. The Trump administration has pushed policies to promote the sovereignty of US drugmakers, threatening tariffs on manufacturers or countries, and vowing to reduce prescription drug prices for Americans.
But it's an approach that could lead to "potential catastrophe", according to Karl Claxton, Professor of Economics at the University of York. "Instead of the US getting to grips with the fact that the healthcare system encourages and incentivises very high-cost medicine, instead of that, they've…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.